Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.
Saved in:
| Title: | Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. |
|---|---|
| Authors: | Howes JM; Division of Cardiovascular & Diabetes Research, Leeds Institute of Genetics Health & Therapeutics, University of Leeds, UK., Richardson VR, Smith KA, Schroeder V, Somani R, Shore A, Hess K, Ajjan R, Pease RJ, Keen JN, Standeven KF, Carter AM |
| Source: | Diabetes & vascular disease research [Diab Vasc Dis Res] 2012 Jul; Vol. 9 (3), pp. 216-25. Date of Electronic Publication: 2012 Jan 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Sage Publications Country of Publication: England NLM ID: 101234011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8984 (Electronic) Linking ISSN: 14791641 NLM ISO Abbreviation: Diab Vasc Dis Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1752-8984 |
|---|---|
| DOI: | 10.1177/1479164111432788 |
